These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9198635)

  • 21. Selective killing of malignant cells from leukemic patients by alkyl-lysophospholipid.
    Verdonck LF; Witteveen EO; van Heugten HG; Rozemuller E; Rijksen G
    Cancer Res; 1990 Jul; 50(13):4020-5. PubMed ID: 2354451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The incidence of submicroscopic deletions in reciprocal translocations is similar in acute myeloid leukemia, BCR-ABL positive acute lymphoblastic leukemia, and chronic myeloid leukemia.
    Bacher U; Schnittger S; Kern W; Hiddemann W; Haferlach T; Schoch C
    Haematologica; 2005 Apr; 90(4):558-9. PubMed ID: 15820957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction chemotherapy and post-remission imatinib therapy for de Novo BCR-ABL-positive AML.
    Lazarevic V; Golovleva I; Nygren I; Wahlin A
    Am J Hematol; 2006 Jun; 81(6):470-1. PubMed ID: 16680752
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effects of a lymph node extract on hemopoietic and lymphoid cells in normal state and in different forms of leukemia].
    Fediakhina RF; Rybakova LP; Tutova IIu
    Eksp Onkol; 1990; 12(4):47-50. PubMed ID: 2379487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Recent advance on chemotherapy of leukemia].
    Nakamura T; Ueda T
    Nihon Naika Gakkai Zasshi; 1994 Sep; 83(9):1531-7. PubMed ID: 7798745
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy of imatinib mesylate as maintenance therapy in adults with acute lymphoblastic leukemia in first complete remission.
    Potenza L; Luppi M; Riva G; Marasca R; Martinelli S; Torelli G
    Haematologica; 2005 Sep; 90(9):1275-7. PubMed ID: 16154854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Allogenic bone marrow transplantation in acute leukemias and chronic myeloid leukemia].
    Mendeleeva LP
    Ter Arkh; 2003; 75(7):89-94. PubMed ID: 12934492
    [No Abstract]   [Full Text] [Related]  

  • 28. [Acute lymphoblastic Ph1-positive leukemia with a hybrid phenotype. The significance of the Ph1 anomaly and the hybrid phenotype].
    Nicoară S; Stefănescu D; Roman S; Tudor F; Butoianu E; Ursea C; Petrescu A; Berceanu S
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1989; 41(1):85-9. PubMed ID: 2573927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Idarubicin in acute leukemia: results of US trials.
    Berman E; Raymond V; Gee TS; Kempin SJ; Gulati S; Andreeff M; Gabrilove J; Young CW; Clarkson BD; Wiernik PH
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():49. PubMed ID: 2713561
    [No Abstract]   [Full Text] [Related]  

  • 30. [Leukemia in childhood].
    Masera G; Adamoli L; Conter V; Piacentini G
    Pediatr Med Chir; 1988; 10(2):133-41. PubMed ID: 3050901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Response and resistance in 300 patients with BCR-ABL-positive leukemias treated with imatinib in a single center: a 4.5-year follow-up.
    Lahaye T; Riehm B; Berger U; Paschka P; Müller MC; Kreil S; Merx K; Schwindel U; Schoch C; Hehlmann R; Hochhaus A
    Cancer; 2005 Apr; 103(8):1659-69. PubMed ID: 15747376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Molecular targeting therapy for leukemia].
    Miyazaki Y
    Gan To Kagaku Ryoho; 2010 May; 37(5):806-10. PubMed ID: 20524248
    [No Abstract]   [Full Text] [Related]  

  • 33. Imatinib mesylate in children and adolescents with cancer.
    Barr RD
    Pediatr Blood Cancer; 2010 Jul; 55(1):18-25. PubMed ID: 20486169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update on the diagnosis of and therapy for acute promyelocytic leukemia and chronic myelogenous leukemia.
    Wujcik D
    Oncol Nurs Forum; 1996 Apr; 23(3):478-87. PubMed ID: 8801508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Classification and characteristics of acute leukemia in children].
    Adachi S
    Nihon Rinsho; 2012 Apr; 70 Suppl 2():665-9. PubMed ID: 23134025
    [No Abstract]   [Full Text] [Related]  

  • 36. Decitabine studies in chronic and acute myelogenous leukemia.
    Kantarjian HM; O'Brien SM; Estey E; Giralt S; Beran M; Rios MB; Keating M; de Vos D; Talpaz M
    Leukemia; 1997 Mar; 11 Suppl 1():S35-6. PubMed ID: 9130691
    [No Abstract]   [Full Text] [Related]  

  • 37. Contrasting features of MDR phenotype in leukemias by using two fluorochromes: implications for clinical practice.
    Vasconcelos FC; Cavalcanti GB; Silva KL; de Meis E; Kwee JK; Rumjanek VM; Maia RC
    Leuk Res; 2007 Apr; 31(4):445-54. PubMed ID: 16979236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Acute myelogenous leukemia and chronic myelogenous leukemia in children].
    Adachi S
    Nihon Rinsho; 2012 Apr; 70 Suppl 2():676-80. PubMed ID: 23134027
    [No Abstract]   [Full Text] [Related]  

  • 39. Progress and Prospects in Pediatric Leukemia.
    Madhusoodhan PP; Carroll WL; Bhatla T
    Curr Probl Pediatr Adolesc Health Care; 2016 Jul; 46(7):229-241. PubMed ID: 27283082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of leukemia with traditional Chinese drugs containing arsenic].
    Zhang T; Chen G; Zhou A
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1998 Oct; 18(10):581-4. PubMed ID: 11477838
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.